STOCK TITAN

Accelerant Holdings (ARX) Financials

ARX
Trailing 12 months to June 30, 2026
Revenue $1.1B YoY not available
Net Income -$1.3B YoY not available
EPS (Diluted) -$6.21 -2922.7% YoY
Operating Cash Flow $45.8M -94.5% YoY
Market Cap $4.3B as of Sep 3, 2026
Price / Sales 3.7x on $1.1B revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 6.0x on $717.4M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ARX SEC filings page.

Accelerant Holdings (ARX) reported $1.1B in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARX FY2025

Revenue expansion is paired with liability-heavy financing and a 2025 accounting loss that did not translate into negative operating cash flow.

In FY2025, the company reported a -$1.35B net loss while producing $445M of operating cash flow, indicating a major accounting-to-cash disconnect rather than a simple cash-generation failure. That disconnect was already visible in FY2024, when $23M of net income accompanied $786M of operating cash flow, so reported earnings and cash generation have not tracked consistently.

Revenue reached $913M in FY2025 while SG&A reached $400M; their similar expansion from FY2024 means growth did not visibly improve this reported expense relationship. The pattern shows costs scaling alongside the top line, without a clear operating-leverage step-up in SG&A.

The balance sheet is more liability-funded than the debt-to-equity ratio implies: FY2025 liabilities were $7.54B against $698M of equity. Debt-to-equity was only 0.2x, suggesting obligations outside long-term debt are central to financing the asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Loss Ratio PremiumGrowth Capital Investment Yield CombinedRatio Stability 27 / 100
Financial Health Score 27/100
Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Accelerant Holdings's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio
25

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Accelerant Holdings scores 25/100 on it among other insurers.

Premium Growth
90

Accelerant Holdings reported revenue of $912.9M in fiscal year 2025, against $602.6M in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Accelerant Holdings scores 90/100 among other insurers.

Capital
16

Accelerant Holdings funded 8.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $697.7M of equity against $8.3B of assets. Capital ranks insurers on that cushion, and Accelerant Holdings scores 16/100 among other insurers.

Investment Yield
0

Not available for Accelerant Holdings, and counted as zero in the overall score.

Combined Ratio
3

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Accelerant Holdings scores 3/100 on it among other insurers.

Stability
26

Accelerant Holdings reported a net loss of $1.3B in fiscal year 2025, against $22.9M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Accelerant Holdings scores 26/100 among other insurers.

Piotroski F-Score Partial
4/6

Accelerant Holdings passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Accelerant Holdings reported a net loss of $1.3B while generating $445.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$356.9M
YoY+62.9%
QoQ+30.6%

Accelerant Holdings generated $356.9M in revenue in Q2 2026. This represents an increase of 62.9% from the same quarter a year earlier. Against the prior quarter it is up 30.6%.

Net Income
$80.0M
YoY+809.1%
QoQ+2051.2%

Accelerant Holdings reported $80.0M in net income in Q2 2026. This represents an increase of 809.1% from the same quarter a year earlier. Against the prior quarter it is up 2051.2%.

EPS (Diluted)
$0.36
YoY+800.0%
QoQ+1900.0%

Accelerant Holdings earned $0.36 per diluted share (EPS) in Q2 2026. This represents an increase of 800.0% from the same quarter a year earlier. Against the prior quarter it is up 1900.0%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$1.6B
YoY+13.3%
QoQ+8.3%

Accelerant Holdings held $1.6B in cash against $120.1M in long-term debt as of Q2 2026.

Shares Outstanding
Diluted avg 220M

Accelerant Holdings had a weighted average of 220M diluted shares in Q2 2026; the shares outstanding count is not reported for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin
22.4%
YoY+18.4pp
QoQ+23.9pp

Accelerant Holdings's net profit margin was 22.4% in Q2 2026, showing the share of revenue converted to profit. This is up 18.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 23.9 percentage points.

Return on Equity
11.2%
YoY+8.6pp
QoQ+11.7pp

Accelerant Holdings's ROE was 11.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$70.4M
QoQ+477.0%

Accelerant Holdings spent $70.4M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 477.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

ARX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARX quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$356.9M+62.9%$273.3M+53.5%$248.4M$267.4M+74.0%$219.1M+68.4%$178.0MN/A$153.7M
SG&A Expenses$129.5M+45.3%$123.8M+64.4%$120.2M$115.8M+72.1%$89.1M+54.2%$75.3MN/A$67.3M
Interest Expense$2.4M-4.0%$2.5M-3.8%$3.2M$2.6M-16.1%$2.5M-16.7%$2.6MN/A$3.1M
Income Tax$7.4M-19.6%$6.1M-20.8%-$3.1M$9.5M+217.3%$9.2M+87.8%$7.7MN/A-$8.1M
Net Income$80.0M+809.1%-$4.1M-152.6%$7.0M-$1.4B-16998.8%$8.8M+197.8%$7.8MN/A$8.1M
EPS (Basic)$0.36+620.0%-$0.02-150.0%$0.44+266.7%-$6.99-14080.0%$0.05+200.0%$0.04$0.12$0.05
EPS (Diluted)$0.36+800.0%-$0.02-166.7%$0.44+300.0%-$6.99-17575.0%$0.04+180.0%$0.03$0.11$0.04
Diluted Shares (Avg)220M+6.7%222M+8.1%N/A206M+3.2%206M+24.1%205MN/A200M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

ARX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARX quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$8.9B+19.3%$8.6B$8.3B+35.6%$7.9B$7.5BN/A$6.1BN/A
Cash & Equivalents$1.6B+13.3%$1.5B+17.3%$1.7B+40.0%$1.6B+50.6%$1.4B+59.3%$1.2B$1.2B$1.1B
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
GoodwillN/AN/A$63.1M+104.2%N/AN/AN/A$30.9MN/A
Total Liabilities$8.2B+16.9%$7.9B$7.5B+33.0%$7.2B$7.0BN/A$5.7BN/A
Long-Term Debt$120.1M-5.2%$120.7M$121.3M-0.1%$121.9M$126.7MN/A$121.4MN/A
Total Equity$717.4M+107.2%$692.6M+52.4%$697.7M+129.3%$676.1M+130.4%$346.2M+22.5%$454.4M$304.3M$293.4M
Retained Earnings-$1.5B-773.7%-$1.5B-$1.5B-740.8%-$1.5B-$167.5MN/A-$182.8MN/A

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

ARX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARX quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$68.6M-131.5%-$21.4M-123.3%$61.9M-74.4%$73.9M-73.3%$217.5M$91.8M$241.8M$276.4M
Depreciation & Amortization$10.4M+25.3%$10.0M+35.1%$9.5M-8.7%$10.0M+72.4%$8.3M+50.9%$7.4M$10.4M$5.8M
Stock-Based Compensation$25.2M+740.0%$28.8M+1100.0%N/A$27.0M+980.0%$3.0M+87.5%$2.4MN/A$2.5M
Investing Cash Flow$269.7M+389.7%-$211.6M-135.9%$64.7M+143.5%-$55.5M+18.6%-$93.1M-$89.7M-$148.9M-$68.2M
Financing Cash Flow-$78.3M-2546.9%-$19.2M-734.8%-$3.7M-103.3%$208.6M+52250.0%$3.2M-$2.3M$113.7M-$400K
Share Buybacks$70.4M$12.2MN/AN/A$0$0N/AN/A

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid.

ARX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARX quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin22.4%+18.4pp-1.5%-5.9pp2.8%-511.9%4.0%+10.9pp4.4%N/A5.3%
Return on Equity11.2%+8.6pp-0.6%-2.3pp1.0%-202.5%-205.2pp2.5%+5.7pp1.7%N/A2.8%
Return on Assets0.9%+0.8pp-0.1%0.1%-17.4%0.1%N/AN/AN/A
Debt-to-Equity0.17-0.2x0.170.17-0.2x0.180.37N/A0.40N/A
Asset Turnover0.040.0x0.030.030.030.03N/AN/AN/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Accelerant Holdings ARX FY2025 $912.9M -$1.3B N/A $4.3B 27/100
Corvel Corp CRVL FY2026 $958.5M $110.3M 11.5% $3.6B 30/100
Goosehead Insura GSHD FY2025 $365.3M $27.8M 7.6% $1.6B 8/100
The Baldwin Group BWIN FY2025 $1.5B -$54.2M -3.6% $3.0B 14/100
Erie Indty Co ERIE FY2025 $4.1B $559.3M 13.8% $13.5B 29/100
Willis Towers WTW FY2025 $9.7B $1.6B 16.5% $31.4B 16/100

Frequently Asked Questions

What is Accelerant Holdings's annual revenue?

Accelerant Holdings (ARX) reported $912.9M in total revenue for fiscal year 2025. This represents a 51.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Accelerant Holdings's revenue growing?

Accelerant Holdings (ARX) revenue grew by 51.5% year-over-year, from $602.6M to $912.9M in fiscal year 2025.

Is Accelerant Holdings profitable?

No, Accelerant Holdings (ARX) reported a net income of -$1.3B in fiscal year 2025.

Accelerant Holdings (ARX) reported diluted earnings per share of -$7.49 for fiscal year 2025. This represents a -5450.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Accelerant Holdings (ARX) had $1.7B in cash and equivalents against $121.3M in long-term debt.

Accelerant Holdings (ARX) has a return on equity of -192.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Accelerant Holdings (ARX) generated $445.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Accelerant Holdings (ARX) had $8.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Accelerant Holdings (ARX) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Accelerant Holdings (ARX) had a return on assets of -16.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Accelerant Holdings (ARX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $4.3B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Accelerant Holdings (ARX) trades at 3.7x sales, its market capitalization divided by revenue of $1.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.3B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Accelerant Holdings (ARX) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Accelerant Holdings (ARX) reported a net loss of $1.3B while generating $445.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Accelerant Holdings (ARX) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top